Study Suggests Potential to Skip Surgery for Selected Breast Cancer Patients
(MedPage Today) -- Women who chose not to have surgery after a pathologic complete response (pCR) to neoadjuvant therapy for early HER2-positive or triple-negative breast cancer (TNBC) had no recurrences during the first 2 years of follow-up, a...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Hematology | HER2 | Neoadjuvant Therapy | Study | Women